Feedback

Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE

  • Bounameaux, Henri
  • Haas, Sylvia
  • Farjat, Alfredo E
  • Ageno, Walter
  • Weitz, Jeffrey I
  • Goldhaber, Samuel Z
  • Turpie, Alexander G G
  • Goto, Shinya
  • Angchaisuksiri, Pantep
  • Nielsen, Joern Dalsgaard
  • Kayani, Gloria
  • Schellong, Sebastian
  • Mantovani, Lorenzo G
  • Prandoni, Paolo
  • Kakkar, Ajay K
Open link
Publication date
January 2020
Icon DOI
10.1016/j.thromres.2020.04.036

Abstract

Randomized controlled trials have shown that direct oral anticoagulants (DOACs) are a safe and effective alternative to vitamin K antagonists (VKAs) for the treatment of venous thromboembolism (VTE). However, there are limited post-marketing data describing the effectiveness and safety of the DOACs in the community setting. We aimed to compare the effectiveness of DOACs and VKAs on 12-month outcomes in a real-world VTE patient population

Extracted data

We use cookies to provide a better user experience.
Data Protection